Typical Antipsychotics - Classic Dopamine Blockers
- Primary Mechanism: Block dopamine D₂ receptors in the central nervous system.
- Effective against positive symptoms (hallucinations, delusions).
- Potency is directly related to D₂ receptor affinity.
- Adverse Effects by Pathway:
- Nigrostriatal Blockade: Causes Extrapyramidal Symptoms (EPS) like dystonia, akathisia, and parkinsonism.
- Tuberoinfundibular Blockade: Disinhibits prolactin release → ↑ Prolactin levels, causing gynecomastia and galactorrhea.

⭐ High-potency agents (e.g., Haloperidol) carry a greater risk of EPS, while low-potency agents (e.g., Chlorpromazine) cause more antihistaminic (sedation), anti-α-adrenergic (orthostasis), and anticholinergic effects.
📌 Mnemonic (High Potency): "Highly Try to Fly" → Haloperidol, Trifluoperazine, Fluphenazine.
Atypical Antipsychotics - Serotonin's Sidekicks
- Dual Action: Primarily block both Dopamine $D_2$ and Serotonin $5HT_{2A}$ receptors.
- Serotonin's Role: $5HT_{2A}$ blockade is key. It ↑ dopamine release in the nigrostriatal pathway, counteracting the motor side effects of $D_2$ blockade.
- Benefit: This dual action leads to a lower risk of Extrapyramidal Symptoms (EPS) compared to typical antipsychotics.
- Variable Receptor Profiles: Many atypicals also have effects at other receptors, contributing to their side-effect profiles:
- H1-antagonism: → Sedation, weight gain
- α1-antagonism: → Orthostatic hypotension

⭐ Clozapine stands out for its minimal $D_2$ blockade and high affinity for $D_4$ receptors, making it highly effective for treatment-resistant schizophrenia but with a risk of agranulocytosis.
📌 Mnemonic: For common atypicals: "All Really Quiet Only Zebras Can Pass" (Aripiprazole, Risperidone, Quetiapine, Olanzapine, Ziprasidone, Clozapine, Paliperidone).
Adverse Effect Pathways - Receptor Roulette
-
Dopamine (D₂ Receptor) Blockade
- Nigrostriatal Pathway: Leads to Extrapyramidal Symptoms (EPS).
- Acute Dystonia: Sudden, sustained muscle contractions.
- Akathisia: Subjective feeling of restlessness.
- Parkinsonism: Bradykinesia, rigidity, tremor.
- Tardive Dyskinesia (TD): Involuntary, repetitive body movements (chronic use).
- Tuberoinfundibular Pathway: ↑ Prolactin levels.
- Causes gynecomastia, galactorrhea, and amenorrhea.
- Nigrostriatal Pathway: Leads to Extrapyramidal Symptoms (EPS).
-
Histamine (H₁ Receptor) Blockade
- Results in sedation and ↑ appetite leading to weight gain.
-
Muscarinic (M₁ Receptor) Blockade
- Anticholinergic effects: Dry mouth, blurred vision, constipation, urinary retention.
- 📌 Mnemonic: "Dry as a bone, blind as a bat, red as a beet, hot as a hare."
-
Alpha-adrenergic (α₁ Receptor) Blockade
- Causes orthostatic hypotension and dizziness.
⭐ Neuroleptic Malignant Syndrome (NMS): A rare but life-threatening emergency from D₂ blockade. Key features are Fever, Encephalopathy, Vitals instability, Elevated enzymes (CK), and Rigidity (“lead-pipe”).
High‑Yield Points - ⚡ Biggest Takeaways
- Typical antipsychotics primarily block D2 receptors in the mesolimbic pathway to treat positive symptoms.
- Atypical antipsychotics combine D2 antagonism with serotonin 5-HT2A receptor blockade, which mitigates the risk of Extrapyramidal Symptoms (EPS).
- D2 blockade in the nigrostriatal pathway is responsible for EPS.
- D2 blockade in the tuberoinfundibular pathway causes hyperprolactinemia.
- Newer agents like aripiprazole exhibit D2 partial agonism, stabilizing dopamine output.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more